The outlook for electric grid reliability in North America is worsening, as demand may outpace supply in the years ahead, according to a key watchdog. In its annual Long-Term Reliability Assessment, ...

Techfluencers everywhere are fawning over Moltbot, AKA Clawdbot, but I'm not convinced. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

This coal plant in central Pennsylvania, once the largest in the state, was shuttered in 2023 after powering the region for over 50 years. Earlier this year, wrecking crews blasted the plant’s cooling ...

Your Android device is a powerhouse of versatility, handling nearly any task from complex productivity workflows to instant global communication. Yet, you may still encounter a frustrating scenario: ...

Imagine trying to navigate an unfamiliar city with a broken compass. The needle appears steady and reliable, instilling confidence in each turn you take. But unbeknownst to you, every step leads you ...

About 170 Starshield satellites built by SpaceX for the US government’s National Reconnaissance Office (NRO) have been sending signals in the wrong direction, a satellite researcher found. The ...

Advances in artificial intelligence are driving surging demand for data centers. But these warehouse-like facilities, containing computers that process and store data, require a lot of land and huge ...

If you plan a trip using AI, triple check that the locations it recommends visiting actually exist. The BBC reports that unsuspecting tourists all over the world are leaning on AI to plan vacations — ...

Data centers are proliferating in Virginia and a blind man in Baltimore is suddenly contending with sharply higher power bills. The Maryland city is well over an hour’s drive from the northern ...

NASHVILLE, Tenn. (AP) — President Donald Trump said Friday he’ll send the National Guard to address crime concerns in Memphis, Tennessee, his latest test of the limits of presidential power by using ...

Ionis Pharmaceuticals has hit a “home run,” according to analysts at Citi, with data in two phase 3 trials that show the ability of Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis ...